3,677 Shares in Danaher Corporation $DHR Purchased by Pincus Capital Management LP

Pincus Capital Management LP acquired a new position in shares of Danaher Corporation (NYSE:DHRFree Report) in the 4th quarter, Holdings Channel reports. The fund acquired 3,677 shares of the conglomerate’s stock, valued at approximately $842,000.

Other large investors have also recently added to or reduced their stakes in the company. Elevated Capital Advisors LLC acquired a new position in Danaher in the 4th quarter valued at approximately $26,000. JPL Wealth Management LLC acquired a new position in Danaher in the 3rd quarter valued at approximately $25,000. WFA of San Diego LLC acquired a new position in Danaher in the 2nd quarter valued at approximately $26,000. ANTIPODES PARTNERS Ltd acquired a new position in Danaher in the 3rd quarter valued at approximately $27,000. Finally, MidAtlantic Capital Management Inc. acquired a new position in Danaher in the 4th quarter valued at approximately $33,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have commented on DHR shares. Evercore upped their price target on Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a report on Tuesday, April 21st. Wall Street Zen cut Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Guggenheim cut their price target on Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Barclays cut their price target on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Finally, Wells Fargo & Company cut their price target on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a report on Wednesday, April 22nd. Nineteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus target price of $238.24.

View Our Latest Analysis on DHR

Danaher Trading Down 1.4%

DHR stock opened at $180.07 on Tuesday. The firm has a market cap of $127.45 billion, a P/E ratio of 34.83, a P/E/G ratio of 2.44 and a beta of 0.81. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The business’s 50 day moving average is $181.91 and its 200-day moving average is $207.20. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The business had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.Danaher’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period in the prior year, the company earned $1.88 EPS. Equities analysts anticipate that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s dividend payout ratio is 30.95%.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.